Bryan Kobel

Bryan Kobel

Chief Executive Officer en TC BIOPHARM (HOLDINGS) PLC .

Fortuna: 773 $ al 30/11/2023

44 años
Finance
Consumer Services
Health Technology

Perfil

Bryan Kobel is currently the Chief Executive Officer & Director at TC Biopharm (Holdings) Plc, as well as the CEO-Biopharm North America and Chief Executive Officer at TC BioPharm (North America), Inc. He previously worked as the Managing Director at Laidlaw & Co. (UK) Ltd.
from 2012 to 2017, Managing Director at The Alberleen Group LLC from 2018 to 2020, and Head-Capital Markets at R.F.
Lafferty & Co., Inc. from 2017 to 2018.
He also served as the Head-Healthcare Investment Banking at HUTN, Inc. Mr. Kobel received his undergraduate degree from Franklin & Marshall College.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
06/02/2024 2 101 ( 0.22% ) 773 $ 30/11/2023

Cargos activos de Bryan Kobel

EmpresasCargoInicio
TC BIOPHARM (HOLDINGS) PLC Chief Executive Officer 01/06/2021
Corporate Officer/Principal -
TC BioPharm (North America), Inc. Chief Executive Officer 01/06/2021
Todos los cargos activos de Bryan Kobel

Antiguos cargos conocidos de Bryan Kobel.

EmpresasCargoFin
Corporate Officer/Principal 01/10/2020
Corporate Officer/Principal 01/06/2018
Corporate Officer/Principal 01/04/2017
HUTN, INC. Corporate Officer/Principal -
Ver el detalle de la experiencia de Bryan Kobel.

Formación de Bryan Kobel.

Franklin & Marshall College Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Bryan Kobel.

Relaciones

17

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas1
HUTN, INC.

Finance

Empresas privadas6

Finance

Finance

Finance

TC Biopharm (Holdings) Plc

Health Technology

TC BioPharm (North America), Inc.

Ver las conexiones de la empresa